Vimarsana
Biggest News Aggregation in the World

Page 17 - Acelyrin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acelyrin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acelyrin Today - Breaking & Trending Today

Acelyrin Appoints Chief Operating Officer | San Fernando Valley Business Journal - Vimarsana News

Acelyrin Appoints Chief Operating Officer | San Fernando Valley Business Journal

Melanie Gloria has been appointed as Acelyrin Inc.’s chief operating officer and will oversee the biopharmaceutical company’s business operations.

Source: sfvbj.com
ACELYRIN Appoints Melanie Gloria as Chief Operating Officer - Vimarsana News

ACELYRIN Appoints Melanie Gloria as Chief Operating Officer

/PRNewswire/ -- ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and...

ACELYRIN Names New COO - socaltech.com - Vimarsana News

ACELYRIN Names New COO - socaltech.com

Los Angeles-based ACELYRIN, a biopharma company focused on unspecified drug candidates, said today that it has named Melanie Gloria as the company's Chief Operating Officer (COO). The company said Gloria

ACELYRIN, INC., Affibody AB, and Inmagene Biopharmaceuticals Announce Positive Interim Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis - Vimarsana News

ACELYRIN, INC., Affibody AB, and Inmagene Biopharmaceuticals Announce Positive Interim Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis

/PRNewswire/ -- ACELYRIN, INC., Affibody AB, and Inmagene Biopharmaceuticals, today announced that a 16-week, global, Phase 2 clinical trial of izokibep in...

ACELYRIN, INC., Affibody AB, and Inmagene Biopharmaceuticals Announce Positive Interim Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis - Vimarsana News

ACELYRIN, INC., Affibody AB, and Inmagene Biopharmaceuticals Announce Positive Interim Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis

/PRNewswire/ -- ACELYRIN, INC., Affibody AB, and Inmagene Biopharmaceuticals, today announced that a 16-week, global, Phase 2 clinical trial of izokibep in...